Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
The effect of graded, physiologic hyperinsulinemia (+5, +15, +30, +70, +200 microU/ml) on oxidative and nonoxidative pathways of glucose and FFA metabolism was examined in nine lean non-insulin dependent diabetic patients (NIDDM) and in eight age- and weight-matched control subjects. Glucose and FFA metabolism were assessed using stepwise insulin clamp in combination with indirect calorimetry and infusion of [3H]3-glucose/[14C]palmitate. The basal rate of hepatic glucose production (HGP) was higher in NIDDM than in control subjects, and suppression of HGP by insulin was impaired at all but the highest insulin concentration. Glucose disposal was reduced in the NIDD patients at the three highest plasma insulin concentrations, and this was accounted for by defects in both glucose oxidation and nonoxidative glucose metabolism. In NIDDs, suppression of plasma FFA by insulin was impaired at all five insulin steps. This was associated with impaired suppression by insulin of plasma FFA turnover, FFA oxidation (measured by [14C]palmitate) and nonoxidative FFA disposal (an estimate of reesterification of FFA). FFA oxidation and net lipid oxidation (measured by indirect calorimetry) correlated positively with the rate of HGP in the basal state and during the insulin clamp. In conclusion, our findings demonstrate that insulin resistance is a general characteristic of glucose and FFA metabolism in NIDDM, and involves both oxidative and nonoxidative pathways. The data also demonstrate that FFA/lipid and glucose metabolism are interrelated in NIDDM, and suggest that an increased rate of FFA/lipid oxidation may contribute to the impaired suppression of HGP and diminished stimulation of glucose oxidation by insulin in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Plasma insulin concentrations such as those observed during the present insulin/glucose or glucose infusion studies, are known to completely suppress hepatic glucose production (27); thus, under these conditions, total glucose uptake is equal to exogenous glucose infusion.”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [27]
In the citing paper
“Notably, insulin resistance is also associated with a decreased ability to suppress lipolysis in adipose tissue and altered fatty acid oxidation.50,51”
From The effects of sleep disruption on metabolism, hunger, and satiety, and the influence of psychosocial stress and exercise: A narrative review (2024) · cites this paper as [51]
In the citing paper
“In lean healthy individuals insulin stimulates glucose uptake into skeletal muscle in a dose-dependent manner, with a half-maximal effect (EC50) at a plasma insulin concentration ~60 μU/mL [21].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“Using the gold standard euglycemic hyperinsulinemic clamp technique to quantify insulin-stimulated glucose uptake, they demonstrated that both lean and obese T2DM subjects have marked decrease (>50%) in whole body glucose disposal during the insulin clamp.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“During the postabsorptive state, the plasma insulin concentration is low. Since the plasma insulin concentration is the principal factor that restrains lipolysis in adipocytes [21] and stimulates glucose uptake in skeletal muscle [21], during the fasting state, muscle glucose uptake is low and the plasma FFA concentration is elevated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“More than 20 years ago Randle and co-workers introduced the concept of substrate competition, whereby enhanced availability and oxidation of FFA leads to an impairment in glucose oxidation (17).”
BackgroundImmunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
Self-citationRegulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 1×
“Since CPT I is inhibited by both insulin and malonyl-CoA, which is generated by condensation of acetyl-CoA (56), the insulin-mediated decline in FFA oxidation could have been due to a direct effect of the hormone on CPT I.”
BackgroundRelationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle
Neely, J. R., & Morgan, H. E. (1974) · Annual Review of Physiology · doi:10.1146/annurev.ph.36.030174.002213 · Cited by 1,261
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167 · cited 2×
“in insulin-mediated glucose metabolism affects both hepatic and peripheral tissues, primarily muscle (1-6).”
BackgroundSelf-citationEffect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Self-citationRadioimmunological determination of human C-peptide in serum
Heding, L. G. (1975) · Diabetologia · doi:10.1007/bf01222104 · Cited by 830
Kolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 629
Cited by
Items 301–400 of 812
Shike, T., Hirose, S., Kobayashi, M., Funabïki, K., Shirai, T., & Tomino, Y. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1943 · Cited by 56
Hother‐Nielsen, O., Møngel, A., Møller, J., Rasmussen, O., Schmitz, O., & Beck‐Nielsen, H. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01903.x · Cited by 56
Rosella, G. (1995) · Molecular Endocrinology · doi:10.1210/me.9.10.1396 · Cited by 56
Basal and insulin-regulated free fatty acid and glucose metabolism in humans
Shadid, S., Kanaley, J. A., Sheehan, M. T., & Jensen, M. D. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00655.2006 · Cited by 55
“It has been reported that glucose disposal during hyperinsulinemia is related to FFM (11), indexes of fatness (10, 11), plasma FFA concentrations (12), and fitness (6), but we could not find evidence that similar influences on insulin-suppressed FFA release have been studied.”
BackgroundSanders, L., Wilcox, M. L., & Maki, K. C. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01150-1 · Cited by 70
Dumas, J., Simard, G., Flamment, M., Ducluzeau, P., & Ritz, P. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.02.002 · Cited by 80
Kampe, K., Sieber, J., Orellana, J. M., Mundel, P. H., & Jehle, A. W. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00454.2013 · Cited by 57
Kim, J. Y., Nasr, A., Tfayli, H. M., Bacha, F. F., Michaliszyn, S. F., & Arslanian, S. A. (2017) · Diabetes · doi:10.2337/db17-0551 · Cited by 63
“Given the important role of insulin in adipose tissue lipolysis (7), an accurate assessment of the relationship between adipose tissue IS (ATIS) and b-cell function would broaden our understanding of adipocyte and b-cell dysfunction in youth with prediabetes and type 2 diabetes.”
BackgroundHow valid are isotopic measurements of fatty acid oxidation?
Heiling, V. J., Miles, J. M., & Jensen, M. D. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.5.e572 · Cited by 56
Metabolic characterization of volume overload heart failure due to aorto-caval fistula in rats
Melenovský, V., Beneš, J., Škaroupková, P., Sedmera, D., Strnad, H., Kolář, M., Vlček, Č., Petrák, J., Beneš, J., Papoušek, F., et al. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0808-3 · Cited by 53
“Because secretion of insulin after a meal suppresses adipose tissue lipolysis [53], relative postprandial hypoinsulinaemia in ACF may contribute to increased FFA release from adipose tissue and to body fat loss.”
BackgroundHome, P. D., & Pacini, G. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00761.x · Cited by 54
Insulin regulation of glucose and lipid metabolism in massive obesity
Prato, S. D., Enzi, G., de Kreutzenberg, S. V., LISATO, G., Riccio, A., Maifreni, L., Iori, E., ZURLO, F., Sergi, G., & Tiengo, A. (1990) · Diabetologia · doi:10.1007/bf00404801 · Cited by 57
“If one assumes a 2% glucose disposal by the whole body [36], it can be calculated that adipose tissue of obese patients was utilizing 0.”
MethodADAMS-HUET, B. A., Devaraj, S., Siegel, D., & Jialal, I. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0092 · Cited by 60
“7,9,17 Thus, if there is insulin resistance in adipose tissue, then this inhibition is removed, resulting in an increase in plasma FFA levels.”
Quantification of Adipose Tissue Insulin Sensitivity
Søndergaard, E., & Jensen, M. D. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000098 · Cited by 53
Is muscle the major site of insulin resistance in Type 2 (non-insulin-dependent) diabetes mellitus?
Gerich, J. E. (1991) · Diabetologia · doi:10.1007/bf00400282 · Cited by 55
“In Type 2 (non-insulin-dependent) diabetes mellitus, both these tissues are resistant to insulin [1-5].”
BackgroundInfluentialChavez, A. O., Kamath, S., Jani, R., Sharma, L. K., Monroy, A., Abdul-Ghani, M. A., Centonze, V. E., Sathyanarayana, P., Coletta, D. K., Jenkinson, C. P., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1387 · Cited by 52
Self-citationFærch, K., & Vaag, A. (2011) · Acta Diabetologica · doi:10.1007/s00592-010-0245-x · Cited by 52
“studies of both non-diabetic and diabetic insulin-resistant individuals [15, 16].”
BackgroundEarly and late endocrine complications of COVID-19
Kazakou, P., Paschou, S. Α., Ψαλτοπούλου, Θ., Gavriatopoulou, M., Korompoki, E., Stefanaki, K., Kanouta, F., Kassi, G., Dimopoulos, M. A., & Mitrakou, A. (2021) · Endocrine Connections · doi:10.1530/ec-21-0184 · Cited by 59
Lima, M. M. S., Targa, A., Noseda, A. C. D., Rodrigues, L. S., Delattre, A. M., dos Santos, F. V., Fortes, M., Maturana, M. J., & Ferraz, A. C. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660155 · Cited by 53
“It is known that adipocytes from individuals with diabetes or obesity are resistant to anti-lipolytic activity of insulin, which contributes to the increase of free fatty acids in plasma [23, 24].”
BackgroundGPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy
Satapati, S., Qian, Y., Wu, M. S., Petrov, A., Dai, G., Wang, S.-P., Zhu, Y., Shen, X., Muise, E. S., Chen, Y., et al. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m075044 · Cited by 50
Relation of the degree of obesity in childhood to adipose tissue insulin resistance
Hagman, E., Besor, O., Hershkop, K., Santoro, N., Pierpont, B., Mata, M., Caprio, S., & Weiss, R. (2019) · Acta Diabetologica · doi:10.1007/s00592-018-01285-3 · Cited by 51
Friedman, J. E., Caro, J., Pories, W. J., Azevedo, J. L., & Dohm, G. L. (1994) · Metabolism · doi:10.1016/0026-0495(94)90188-0 · Cited by 55
Secondary failure of oral hypoglycaemic agents: Frequency, possible causes, and management
Pontiroli, A. E., Caiderara, A., & Pozza, G. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100104 · Cited by 54
Bergman, B. C., Howard, D., Schauer, I. E., Maahs, D. M., Snell-Bergeon, J. K., Clement, T. W., Eckel, R. H., Perreault, L., & Rewers, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2892 · Cited by 51
Belfiore, F., Iannello, S., Camuto, M., Fagone, S., & Cavaleri, A. (2001) · Metabolism · doi:10.1053/meta.2001.22518 · Cited by 48
Bell, P. M., & Hadden, D. R. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70265-6 · Cited by 66
López-Palau, N. E., & Olais-Govea, J. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-69629-0 · Cited by 56
Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies
Meece, J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x167336 · Cited by 50
7 Insulin action and substrate competition
Groop, L., & Ferrannini, E. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80243-5 · Cited by 54
Self-citationAlqahtani, N., Khan, W. A. G., Alhumaidi, M. H., & Ahmed, Y. (2013) · Europe PMC (PubMed Central) · Cited by 51
Fromentin, C., Tomé, D., Nau, F., Flet, L., Luengo, C., Azzout-Marniche, D., Sanders, P., Fromentin, G., & Gaudichon, C. (2013) · Diabetes · doi:10.2337/db12-1208 · Cited by 50
Rozance, P. J., Limesand, S. W., Barry, J. S., Brown, L. D., Wesolowski, S. R., LoTurco, D., Regnault, T. R. H., Friedman, J. E., & Hay, W. W. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00639.2007 · Cited by 53
“One of the hallmarks of type 2 diabetes is reduced ability of insulin to suppress hepatic glucose production (22).”
BackgroundMetabolic effects of liver transplantation in cirrhotic patients.
Luzi, L., Perseghin, G., Regalia, E., Sereni, L. P., Battezzati, A., Baratti, D., Bianchi, E., Terruzzi, I., Hilden, H., Groop, L., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119213 · Cited by 52
“FFA oxidation rate was calculated from (14)CO2 expired in the three sampling periods accordingly to the formula previously described (18).”
BackgroundMethodSelf-citationArii, K., Suehiro, T., Yamamoto, M., Ito, H., & Hashimoto, K. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90211-0 · Cited by 52
Koopmans, S. J., Kushwaha, R. S., & DeFronzo, R. A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90081-1 · Cited by 48
Self-citationKato, K., Takeshita, Y., Misu, H., Zen, Y., Kaneko, S., & Takamura, T. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12271 · Cited by 48
Tian, N., Wang, J., Wang, P., Song, X., Yang, M., & Kong, L. (2013) · Metabolomics · doi:10.1007/s11306-013-0535-8 · Cited by 48
“The insulin insensitivity in diabetes rats led to increased blood plasma levels of nonesterified fatty acids (Groop et al. 1989), whose partial boxidation in liver and skeletal muscle produced excess ketone bodies.”
BackgroundStrong association between insulin resistance in liver and skeletal muscle in non‐diabetic subjects
Abdul‐Ghani, M. A., Matsuda, M., & DeFronzo, R. A. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02597.x · Cited by 48
Self-citationPathophysiology of type 2 diabetes: targeting islet cell dysfunction.
Spellman, C. (2010) · PubMed · Cited by 61
O’Brien, T. P., Jenkins, E. C., Estes, S. K., Castaneda, A. V., Ueta, K., Farmer, T. D., Puglisi, A. E., Swift, L. L., Printz, R. L., & Shiota, M. (2017) · Diabetes · doi:10.2337/db16-1410 · Cited by 48
Identification and characterization of PRKCBP1, a candidate RACK-like protein
Fossey, S. C., Kuroda, S., Price, J. A., Pendleton, J. K., Freedman, B. I., & Bowden, D. W. (2000) · Mammalian Genome · doi:10.1007/s003350010174 · Cited by 49
Zhou, L., Wang, X., Yang, Y., Wu, L., Li, F., Zhang, R., Yuan, G., Wang, N., Chen, M., & Ning, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.001 · Cited by 51
“Obesity and type 2 diabetes mellitus are associated with increased levels of circulating FFA, which are thought to induce insulin resistance [29].”
BackgroundÖstenson, C.-G., Sandberg-Nordqvist, A.-C., Chen, J., Hällbrink, M., Rotin, D., Langel, Ü., & Efendić, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6536 · Cited by 47
LINDAHL, B., ASPLUND, K., & HALLMANS, G. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00742.x · Cited by 48
Wang, W., Zhong, X., & Guo, J. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4947 · Cited by 54
Lane, R. H., MacLennan, N. K., Daood, M. J., Hsu, J. L., Janke, S. M., Pham, T. D., Puri, A. R., & Watchko, J. F. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000064583.40495.51 · Cited by 48
“An important component contributing to the pathogenesis of skeletal muscle insulin resistance is altered fatty acid homeostasis (6, 7).”
BackgroundCarlsson, M., Orho‐Melander, M., Hedenbro, J., & Groop, L. (2001) · Diabetologia · doi:10.1007/s001250051670 · Cited by 53
Self-citationFerrannini, E., Gastaldelli, A., Matsuda, M., Miyazaki, Y., Pettiti, M., Glass, L., & DeFronzo, R. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021864 · Cited by 46
Self-citationAl-Sayyar, A., Hulme, K. D., Thibaut, R., Bayry, J., Sheedy, F. J., Short, K. R., & Alzaïd, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.919223 · Cited by 61
Pathophysiology of diabetes mellitus type 2: beyond the duo "insulin resistance-secretion deficit".
Boada, C. A. C., & Martínez-Moreno, J. M. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6717 · Cited by 79
Adenosine effects upon insulin action on lipolysis and glucose transport in human adipocytes
Heseltine, L., Webster, J. M., & Taylor, R. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf00944394 · Cited by 51
“This could bring about practical benefit in non-insulin dependent diabetes, a state characterised by high circulating fatty acid levels, hyperglycaemia and decreased basal rates of glucose oxidation [1,2].”
BackgroundVuorinen-Markkola, H., Yki-J�rvinen, H., & Taskinen, M. (1993) · Diabetologia · doi:10.1007/bf00400699 · Cited by 46
“Since suppression of non-esterified fatty acids (NEFA) by insulin is impaired not only in Type 2 diabetic patients [10] but also in hypertriglyceridaemic subjects [2] an increased availability of circulating NEFA could impair insulin action on glucose metabolism in both disorders.”
BackgroundMethodTurk, D., Alzaid, A., Dinneen, S., Nair, K. S., & Rizza, R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117723 · Cited by 45
Maiorana, A., Bianco, C. D., & Cianfarani, S. (2007) · The Review of Diabetic Studies · doi:10.1900/rds.2007.4.134 · Cited by 53
“In the liver, insulin resistance results in the impaired ability of insulin to suppress hepatic glucose production (HGP) [27-29] (Figure 2).”
BackgroundClore, J. N., Post, E. P., Bailey, D. J., Nestler, J. E., & Blackard, W. G. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1740502 · Cited by 46
Vangipurapu, J., Stančáková, A., Pihlajamäki, J., Kuulasmaa, T., Kuulasmaa, T., Paananen, J., Kuusisto, J., Ferrannini, E., & Laakso, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1977-4 · Cited by 45
“This marker reflecting adipocyte IR is based on a study [22] demonstrating that insulin is a strong inhibitory stimulus for lipolysis and suppresses NEFA levels.”
BackgroundSelf-citationA low resting metabolic rate is associated with metabolic syndrome
Buscemi, S., Verga, S., Caimi, G., & Cerasola, G. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.08.010 · Cited by 45
Riemens, S. C., Sluiter, W. J., & Dullaart, R. P. F. (2000) · Diabetologia · doi:10.1007/s001250051324 · Cited by 46
Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes
Wu, C., Okar, D. A., Newgard, C. B., & Lange, A. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2002.282.1.e38 · Cited by 52
“In type 2 diabetes, suppression of HGP by insulin is impaired (13, 34).”
BackgroundEffect of insulin and plasma amino acid concentration on leucine metabolism in cirrhosis
Petrides, A. S., Luzi, L., Reuben, A., Riely, C. A., & DeFronzo, R. A. (1991) · Hepatology · doi:10.1002/hep.1840140306 · Cited by 47
Self-citationFree Fatty Acids Reduce Splanchnic and Peripheral Glucose Uptake in Patients With Type 2 Diabetes
Bajaj, M., Pratipanawatr, T., Berria, R., Pratipanawatr, W., Kashyap, S., Cusi, K., Mandarino, L., & DeFronzo, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3043 · Cited by 45
“Tritiated glucose specific activity was determined on deproteinized bariun/ zinc plasma samples as previously described (9).”
MethodSelf-citationJohnson, A. B., Argyraki, M., Thow, J. C., Jones, I. R., Broughton, D., Miller, M. A., & Taylor, R. (1991) · Metabolism · doi:10.1016/0026-0495(91)90106-7 · Cited by 44
Wang, X., Gu, C., He, W., Ye, X., Chen, H., Zhang, X., & Hai, C. (2012) · Biochimie · doi:10.1016/j.biochi.2012.03.024 · Cited by 46
Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance
Shannon, C. E., Merovci, A., Xiong, J., Tripathy, D., Lorenzo, F., McClain, D. A., Abdul-Ghani, M. A., Norton, L., & DeFronzo, R. A. (2018) · Diabetes · doi:10.2337/db18-0439 · Cited by 44
“In skeletal muscle, the defect in insulin action involves multiple intracellular steps in glucosemetabolism, including glucose oxidation and glycogen synthesis (1,2,11,12).”
BackgroundSelf-citationSugimoto, D., Tamura, Y., Takeno, K., Kaga, H., Someya, Y., Kakehi, S., Funayama, T., Furukawa, Y., Suzuki, R., Kadowaki, S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02190 · Cited by 48
Gu, Q., Hu, X. F., Meng, J., Ge, J., Wang, S. J., & Liu, X. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3214716 · Cited by 43
“Furthermore, IR/hyperinsulinemia can not only reduce the excretion of urate but also contribute to its overproduction.”
BackgroundIs insulin resistance atherogenic? Possible mechanisms
DeFronzo, R. A. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.05.002 · Cited by 46
Self-citationHigh blood ketone body concentration in Type 2 non-insulin dependent diabetic patients
Avogaro, A., Crepaldi, C., Miola, M., Maran, A., Pengo, V., Tiengo, A., & Prato, S. D. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03349844 · Cited by 44
Jørgensen, S. W., Hjort, L., Gillberg, L., Justesen, L., Madsbad, S., Brøns, C., & Vaag, A. A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2020 · Cited by 43
“It was shown previously that the elevated basal hepatic glucose production in hyperinsulinemic type 2 diabetic patients is closely associated with a lower responsiveness to the suppression of the rate of hepatic glucose production during experimental exogenous (clamp) low-grade physiologic hyperinsulinemia, providing…”
BackgroundMazibuko-Mbeje, S. E., Dludla, P. V., Johnson, R., Joubert, E., Louw, J., Ziqubu, K., Tiano, L., Silvestri, S., Orlando, P., Opoku, A. R., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216172 · Cited by 44
Effects of SGLT2 inhibition on lipid transport in adipose tissue in type 2 diabetes
Lauritsen, K. M., Voigt, J. H., Pedersen, S. B., Hansen, T. K., Møller, N., Jessen, N., Gormsen, L. C., & Søndergaard, E. (2022) · Endocrine Connections · doi:10.1530/ec-21-0558 · Cited by 45
“An important hallmark of type 2 diabetes is increased lipolysis and reduced adipose tissue insulin sensitivity (the ability of insulin to suppress lipolysis) (37).”
Difference and Similarity Between Non‐Alcoholic Steatohepatitis and Alcoholic Liver Disease
Kojima, H., Sakurai, S., Uemura, M., 竹川, 隆., Morimoto, H., 玉川泰浩, & Fukui, H. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000191776.37626.30 · Cited by 42
How to measure hepatic insulin resistance?
Choukem, S. P., & Gautier, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74602-0 · Cited by 57
“Insulin sensitivity to lipid metabolism can be assessed by many methods; the most commonly used is the measurement of NEFA suppression in response to insulin infusion [3-5].”
BackgroundMethodREGULATION OF ENERGY METABOLISM
Brody, T. (1999) · Elsevier eBooks · doi:10.1016/b978-012134836-6/50007-x · Cited by 45
Seghieri, G., Yin, W., Boni, C. D., Sanna, G., Anichini, R., Bartolomei, G., & Ferrannini, E. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01882.x · Cited by 41
Self-citationSalinari, S., Carr, R. D., Guidone, C., BERTUZZI, A., Cercone, S., Riccioni, M. E., Manto, A., Ghirlanda, G., & Mingrone, G. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00559.2012 · Cited by 42
“In this regard, it has been ascertained that impaired insulin suppression of NEFA reflects NEFA flux from the adipose tissue rather than impaired NEFA uptake (13, 14).”
BackgroundMechanism of differential effects of antihypertensive agents on serum lipids
Brook, R. D. (2000) · Current Hypertension Reports · doi:10.1007/s11906-000-0040-0 · Cited by 43
Impaired adrenergic response to prolonged exercise in type I diabetes
Schneider, S. H., Vitug, A. C., Ananthakrishnan, R., & Khachadurian, A. K. (1991) · Metabolism · doi:10.1016/0026-0495(91)90219-m · Cited by 41
Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients
Pigon, J. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3702 · Cited by 41
Schalin-J�ntti, C., Yki-J�rvinen, H., Koranyi, L. I., Bourey, R. E., Lindstr�m, J., Nikula-Ijäs, P., Franssila-Kallunki, A., & Groop, L. (1994) · Diabetologia · doi:10.1007/bf00408478 · Cited by 39
“reduced glucose disposal in skeletal muscle [2, 3].”
Self-citationInsulin Resistance and Insulin Sensitizers
Stumvoll, M., & Häring, H. (2001) · Hormone Research in Paediatrics · doi:10.1159/000063466 · Cited by 40
Kristian, R. E. T. T. (1999) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.0010s1008.x · Cited by 43
Jun, H., Bae, H. Y., Lee, B. R., Koh, K. S., Kim, Y., Lee, K. W., Kim, H., & Yoon, J. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00071-4 · Cited by 47
Saloranta, C., Groop, L., Ekstrand, A., Franssila-Kallunki, A., Eriksson, J. G., & Taskinen, M. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb00011.x · Cited by 38
Self-citationInsulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM
Colosimo, S., Mitra, S. K., Chaudhury, T., & Marchesini, G. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111016 · Cited by 38
Choukem, S. P., Sobngwi, E., Fetita, L.-S., Boudou, P., de Kerviler, É., Boirie, Y., Hainault, I., Vexiau, P., Mauvais‐Jarvis, F., Calvo, F. M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0914 · Cited by 43
“(20) and are usually considered as characteristic features of type 2 diabetes (21,22).”
BackgroundA Model of NEFA Dynamics with Focus on the Postprandial State
Jelic, K., Hallgreen, C. E., & Colding‐Jørgensen, M. (2009) · Annals of Biomedical Engineering · doi:10.1007/s10439-009-9738-6 · Cited by 40
Interactions Between Glucose and FFA Metabolism in Man
Saloranta, C., & Groop, L. (1996) · Diabetes/Metabolism Reviews · doi:10.1002/(sici)1099-0895(199603)12:1<15::aid-dmr153>3.0.co;2-0 · Cited by 47
Self-citationByrne, C. D., Maison, P., Halsall, D. J., Martensz, N. D., Hales, C. N., & Wareham, N. J. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00184.x · Cited by 39
Kamath, S., Chávez, A. O., Gastaldelli, A., Casiraghi, F., Halff, G. A., ABRAHAMIAN, G. A., Davalli, A. M., Bastarrachea, R. A., Comuzzie, A. G., Guardado‐Mendoza, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027617 · Cited by 41
“Additionally, in order to further characterize insulin sensitivity profiles in peripheral tissues in our study population we calculated the adipose tissue insulin resistance index as the product of fasting NEFA6FPI, since insulin suppresses lipolysis and NEFA delivery to circulation by adipocytes [23].”
BackgroundInfluentialSelf-citationType 2 Diabetes: An Expanded View of Pathophysiology and Therapy
Unger, J., & Parkin, C. G. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.05.2152 · Cited by 42
“The antilipolytic effect of insulin is markedly impaired in lean patients with diabetes.(26) Elevated plasma FFA levels antagonize insulin action and are the cornerstone of insulin resistance, reduced β-cell response to hyperglycemia, and genetically programmed β-cell apoptosis.”
BackgroundEvaluation of quantitative models of the effect of insulin on lipolysis and glucose disposal
Periwal, V., Chow, C. C., Bergman, R. N., Ricks, M., Vega, G. L., & Sumner, A. E. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90426.2008 · Cited by 36
“Previous studies indicate that there may be a maximally suppressible level of FFA plasma appearance ( 11 , 12, 15, 16, 18).”
BackgroundDeterminants of intramyocellular lipid accumulation after dietary fat loading in non-obese men
Sakurai, Y., Tamura, Y., Takeno, K., Kumashiro, N., Sato, F., Kakehi, S., Ikeda, S., Ogura, Y., Saga, N., Naıto, H., et al. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00091.x · Cited by 39
Correlates of insulin clearance in apparently healthy non-obese Japanese men
Kaga, H., Tamura, Y., Takeno, K., Kakehi, S., Funayama, T., Furukawa, Y., Nishitani‐Yokoyama, M., Shimada, K., Daida, H., Aoki, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01469-x · Cited by 37
Zhang, K., Pan, H., Wang, L., Yang, H., Zhu, H., & Gong, F. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291350 · Cited by 40
“However, the suppressive role of insulin on lipolysis is weakened in obese individuals.(2) This impaired antilipolytic effect of insulin in adipose tissue is called adipose tissue insulin resistance.”
BackgroundInfluentialObesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Mocciaro, G., & Gastaldelli, A. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_573 · Cited by 48
Hyperlipidemia and Hyperinsulinemia in the Spontaneous Osteoarthritis Mouse Model, STR/Ort
Uchida, K., Urabe, K., Naruse, K., Ogawa, Z., Mabuchi, K., & Itoman, M. (2009) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.58.181 · Cited by 42
Gastaldelli, A., Casolaro, A., Ciociaro, D., Frascerra, S., Nannipieri, M., Buzzigoli, E., & Ferrannini, E. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90960.2008 · Cited by 36
Self-citationCharacterization of the Prediabetic State
Groop, L. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00149-0 · Cited by 37
“In general, both insulin resistance and impaired insulin secretion are required to manifest NIDDM.(10,11) Insulin resistance could represent a primary genetic defect in skeletal muscle or develop as the consequence of obesity.”
BackgroundSelf-citationAging human abdominal subcutaneous white adipose tissue at single cell resolution
Whytock, K. L., Divoux, A., Sun, Y., Pino, M. F., Yu, G., Jin, C. A., Robino, J. J., Plekhanov, A., Varlamov, O., Smith, S. R., et al. (2024) · Aging Cell · doi:10.1111/acel.14287 · Cited by 41
“Adipose tissue insulin resistance index (ADIPO-IR) was calculated by multiplying plasma FFA (mmol/L) by serum insulin (pmol/L) (Groop et al., 1989; Søndergaard et al., 2017).”
Metadata
- Authors
- Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- University of Helsinki (FI)
- Venue
- Journal of Clinical Investigation
- Published
- 1989-07-01
- Volume
- 84
- Issue
- 1
- Pages
- 205-213
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC303971
- OpenAlex
- W1981456793
- Cited by
- 812
- References
- 61
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 28 · 2023: 15 · 2022: 27 · 2021: 30 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 32 · 2016: 26 · 2015: 22 · 2014: 22 · 2013: 26 · 2012: 26
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health (AM 24 092)
- Fogarty International Center (F05-TWO-3451)
- National Center for Research Resources (RR 125)
- Ministero dell'Istruzione e del Merito
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- type 2 diabetes, insulin resistance, glucose metabolism, free fatty acid metabolism, hepatic glucose production, glucose oxidation, nonoxidative glucose metabolism, fatty acid oxidation, fatty acid re-esterification, hyperinsulinemia, insulin clamp, lipid oxidation
- MeSH terms
- Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Oxidation-Reduction, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.